Getnb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Getnb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Getnb Today - Breaking & Trending Today

Analysts Set 89bio, Inc. (NASDAQ:ETNB) PT at $29.00

Shares of 89bio, Inc. (NASDAQ:ETNB – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month […] ....

United States , Dekabank Deutsche Girozentrale , Rohan Palekar , Vanguard Group Inc , Charles Schwab Investment Management Inc , Westfield Capital Management Co , Securities Exchange Commission , Cantor Fitzgerald , Get Free Report , Director Ra Capital Management , Exchange Commission , Schwab Investment Management , Capital Management , Bank Deutsche Girozentrale , Vanguard Group , Get Free , Nasdaq Etnb ,

Head-To-Head Survey: 89bio (NASDAQ:ETNB) versus 2seventy bio (NASDAQ:TSVT)

89bio (NASDAQ:ETNB – Get Free Report) and 2seventy bio (NASDAQ:TSVT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Profitability This table compares 89bio and 2seventy bio’s […] ....

United Kingdom , United States , San Francisco , Bristol Myers Squibb Company , Get Free Report , Bristol Myers Squibb , Nasdaq Etnb , Stock Comparison , Stock Analysis ,

89bio, Inc. (NASDAQ:ETNB) Receives $28.83 Consensus Target Price from Analysts

89bio, Inc. (NASDAQ:ETNB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price target among […] ....

Rohan Palekar , Securities Exchange Commission , Westfield Capital Management Co , Alpine Global Management , Charles Schwab Investment Management Inc , Company Profile , Marshall Wace , Eagle Asset Management Inc , Royal Bank , Cantor Fitzgerald , Get Free Report , Marketbeat Ratings , Director Ra Capital Management , Exchange Commission , Schwab Investment Management , Capital Management , Asset Management , Get Free , Nasdaq Etnb ,

89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by HC Wainwright

89bio (NASDAQ:ETNB – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $31.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 171.45% from the […] ....

Rohan Palekar , Alpine Global Management , Cantor Fitzgerald , Charles Schwab Investment Management Inc , Company Profile , Marshall Wace , Securities Exchange Commission , Royal Bank , Eagle Asset Management Inc , Westfield Capital Management Co , Get Free Report , Director Ra Capital Management , Exchange Commission , Schwab Investment Management , Capital Management , Asset Management , Nasdaq Etnb , Reiterated Rating , Hc Wainwright ,

89bio (ETNB) – Analysts' Recent Ratings Changes

89bio (NASDAQ: ETNB) has recently received a number of price target changes and ratings updates: 3/6/2024 – 89bio had its price target raised by analysts at Evercore ISI from $29.00 to $37.00. They now have an “outperform” rating on the stock. 3/5/2024 – 89bio had its “market perform” rating reaffirmed by analysts at Oppenheimer Holdings […] ....

Rohan Palekar , Wetzel Investment Advisors Inc , Us Bancorp , Royal Bank , Cantor Fitzgerald , Inc Daily , Acadian Asset Management , Oppenheimer Holdings Inc , Get Free Report , Director Ra Capital Management , Investment Advisors , Asset Management , Forest Capital Management , 89bio Inc , Nasdaq Etnb ,